EVOFEM BIOSCIENCES INC(NASDAQ:EVFM) stock News

EVFM Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Halper Sadeh LLC - Mentions: MLNK BFIN MRCC

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MLNK, BFIN, MRCC, EVFM on Behalf of Shareholders

a month ago - By: The Motley Fool

Evofem Revenue Jumps 16 Percent in Q2

5 months ago - By: Evofem Biosciences, Inc.

Evofem Biosciences to Present at Emerging Growth Conference

6 months ago - By: Evofem Biosciences, Inc.

Evofem Expects Significant Reduction in PHEXXI Manufacturing Cost Through Agreement with Windtree Therapeutics

6 months ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Reports Fourth Consecutive Year of Net Sales Growth

a year ago - By: BusinessInsider

EVFM Stock Earnings: Evofem Biosciences Reported Results for Q2 2024

a year ago - By: InvestorPlace

EVFM Stock Earnings: Evofem Biosciences Reported Results for Q2 2024

a year ago - By: InvestorPlace

EVFM Stock Earnings: Evofem Biosciences Reported Results for Q1 2024

7 months ago - By: Evofem Biosciences, Inc.

Evofem Strengthens SOLOSEC Intellectual Property with New U.S. Patent from USPTO

9 months ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic ADI Platform, Advancing Toward First-in-Human Clinical Trials

10 months ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Biosciences Announces Financial Results for the Third Quarter of 2024

10 months ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares

a year ago - By: InvestorPlace

EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023

10 months ago - By: Aditxt, Inc. - Mentions: ADTX OTC APLI.CA

Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem

11 months ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time

11 months ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives

a year ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Aditxt to Host a Virtual Fireside Chat with Aditxt CEO Amro Albanna and Evofem CEO Saundra Pelletier, Moderated by MD & Media Personality Dr. Drew Pinsky, on October 28, 2024, at 11:30 AM Eastern Time

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem

a year ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt Delivers Shareholder Update and 2024 Year-End Plan

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt

a year ago - By: Invezz - Mentions: ADTX

InvestorNewsBreaks – Aditxt (NASDAQ: ADTX) Subsidiary Signs Agreement with Evofem Biosciences Inc. (OTCQB: EVFM) Involving Unique Endometriosis Diagnostic Test

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Aditxt’s Subsidiary Pearsanta to Collaborate with Evofem Biosciences for Targeted U.S. Launch of Endometriosis Diagnostic in Mid-2025

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Aditxt and Evofem Sign Second Amendment to Amended and Restated Merger Agreement, Target Closing of Acquisition in Fourth Quarter of 2024

a year ago - By: Aditxt, Inc. - Mentions: ADTX APLI.CA OTC

Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution

a year ago - By: Invezz - Mentions: ADTX

BioMedNewsBreaks — Evofem Biosciences Inc. (EVFM) Releases Second-Quarter 2024 Financial Results, Company Update

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Biosciences Announces Financial Results for the Second Quarter of 2024

a year ago - By: Virtual Investor Conferences - Mentions: AERG HC.CA BET.CA SIGY ...

OTCQB Venture Virtual Investor Conference Presentations Now Available for On-Demand Viewing

a year ago - By: Virtual Investor Conferences - Mentions: AERG HC.CA BET.CA SIGY ...

OTCQB Venture Virtual Investor Conference Agenda Announced for August 1st

a year ago - By: Virtual Investor Conferences - Mentions: ADTX

Evofem Biosciences to Present at the OTCQB Venture Virtual Investor Conference on August 1st

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Signs Phexxi® License Agreement for Middle East with Pharma 1

a year ago - By: Aditxt, Inc. - Mentions: ADTX

Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing

a year ago - By: Lupin Limited - Mentions: ADTX

Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Hello Alpha Partners with Evofem to Offer Phexxi® as a Hormone-Free Contraception Solution on its Platform for Women's Healthcare

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter

a year ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

Evofem Biosciences Announces Financial Results for the First Quarter of 2024

a year ago - By: Evofem Biosciences, Inc.

Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO

a year ago - By: Evofem Biosciences, Inc.

Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023

2 years ago - By: Evofem Biosciences, Inc. - Mentions: ADTX

For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy

EVOFEM BIOSCIENCES INC (EVFM) Stock News

EVFM Latest News, Press Relases and Analysis